Wednesday, February 10, 2010, 1:20PM AEST - The Australian Stockmarket closes in 2 hours and 45 minutes.
To create a watchlist or portfolio of shares, Register

Genzyme Corp. (GENZ)

8:00AM AEST: 54.87 USD  Up 0.38 (0.70%)  
 MORE ON GENZ 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Genzyme Corporation (NasdaqNM:GENZ) Delayed quote dataEdit
Last Trade:54.87 USD
Trade Time: 8:00AM AEST
Change:Up 0.38 (0.70%)
Prev Close:54.49
Open:55.02
Bid:54.35 x 300
Ask:55.23 x 200
1y Target Est:55.53
Day's Range:54.27 - 55.47
52wk Range:47.09 - 73.75
Volume:2,267,418
Avg Vol (3m):3,449,710
Market Cap:14.56B
P/E (ttm):31.28
EPS (ttm):1.75
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add GENZ to Portfolio   Download Data

 HEADLINES 
Targeted Genetics completes $7M Genzyme deal
at bizjournals.com (Wed 3:05AM)
Weekly Street Sentiment: Sell-Side Still Searching for Direction
at Seeking Alpha (Tue 8:52PM)
PREVIEW-Genzyme competition may get clearer at conference
at Reuters (Tue 6:37AM)
GSK: Rare Diseases Now Big Business
at The Wall Street Journal Online (Tue 2:56AM)
5 Beaten Down Stocks Ready For Reversal
at Investopedia (Sat, Feb 6)
Biotech Stock Mailbag: Soligenix
at TheStreet.com (Fri, Feb 5)
My Favorite Investor
at Motley Fool (Fri, Feb 5)
Biotech Stocks: Pfizer leads drug stocks south
at MarketWatch (Thu, Feb 4)
Pfizer's Hedge Pays Off
at Motley Fool (Thu, Feb 4)
Genzyme names global manufacturing president
AP (Thu, Feb 4)
UPDATE - Genzyme names ex-Lilly exec to head manufacturing
at Reuters (Thu, Feb 4)
Ahead of the Bell: Genzyme upgraded to 'Buy'
AP (Thu, Feb 4)
More Headlines for GENZ...

 ANALYST 
EPS Est (next year) (Dec-09) :2.24
EPS Est (in 2 years) (Dec-10) :3.43
Avg Rec (current)*:2.4
PEG Ratio:1.17
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Genzyme Corporation operates as a biotechnology company worldwide. The company’s Genetic Diseases segment manufactures and distributes therapeutic products, including Cerezyme as an enzyme replacement therapy for the treatment of Type 1 and T...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices